Brief: Kinnate Biopharma posts Q1 basic EPS USD -0.73
11/05/2023 21:07
May 11 (Reuters) - Kinnate Biopharma Q1 operating expenses USD 34.653 million. * Q1 basic EPS USD -0.73 * Q1 net income USD -32.94 million * Q1 operating income USD -34.653 million
Recent news on Kinnate Biopharma
See all newsKinnate Biopharma Inc reports results for the quarter ended in December - Earnings Summary
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: XOMA Announces Calculation Of Additional Price Per Share And Extension Of Expiration Date For Tender Offer For Kinnate Biopharma Inc
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Kinnate Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview